利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

17 条记录 (耗时 0.036 秒)

    Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
    7.
    发明授权
    Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer 失效
    咪唑烷酰氨基嘧啶化合物治疗癌症

    公开(公告)号：US08063212B2

    公开(公告)日：2011-11-22

    申请号：US12516251

    申请日：2007-12-11

    申请人： Harold Burns Brooks ,  Joyce Z. Crich ,  James Robert Henry ,  Hong-Yu Li ,  Jason Scott Sawyer ,  Yan Wang

    发明人： Harold Burns Brooks ,  Joyce Z. Crich ,  James Robert Henry ,  Hong-Yu Li ,  Jason Scott Sawyer ,  Yan Wang

    IPC分类号： C07D401/00

    CPC分类号： C07D409/14

    摘要： The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. Formula I wherein: R1 is aminomethyl, (C1-C3 alkyl)aminomethyl, di(C1-C2 alkyl)aminomethyl, N-ethyl-N-methyl-aminomethyl, 1-aminoethyl, 1-((C1-C2 alkyl)amino)-ethyl, 3,3,3-trifluoro-propylaminomethyl, ethynyl, 2-hydroxy-ethoxy, 2-hydroxyethylaminomethyl, 2-cyanoethylaminomethyl, morpholin-4-ylmethyl, methoxymethoxymethyl, cyclopropyl, 1-azetidinylmethyl, 1-pyrrolidinylmethyl, or 1,3-dioxolan-2-yl; R2 is hydrogen or halo; R3 is hydrogen or halo; provided that at least one of R2 and R3 is hydrogen; R4 is hydrogen, methyl, or halo; and is a single bond that is either present or absent, or pharmaceutically acceptable salt thereof.

    摘要翻译： 本发明提供了被认为具有通过抑制Plk1治疗癌症的临床用途的新型咪唑烷基氨基嘧啶化合物。 式（I）其中：R1是氨基甲基，（C1-C3烷基）氨基甲基，二（C1-C2烷基）氨基甲基，N-乙基-N-甲基 - 氨基甲基，1-氨基乙基，1-（（C1-C2烷基）氨基） 乙基，3,3,3-三氟 - 丙氨基甲基，乙炔基，2-羟基 - 乙氧基，2-羟乙基氨基甲基，2-氰乙基氨基甲基，吗啉-4-基甲基，甲氧基甲氧基甲基，环丙基，1-氮杂环丁基甲基，1-吡咯烷基甲基， 3-二氧戊环-2-基; R2是氢或卤素; R3是氢或卤素; R2和R3中的至少一个是氢; R4是氢，甲基或卤素; 并且是存在或不存在的单键或其药学上可接受的盐。

    IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER
    8.
    发明申请
    IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER 失效
    用于治疗癌症的咪达唑仑胺氨基嘧啶化合物

    公开(公告)号：US20100081641A1

    公开(公告)日：2010-04-01

    申请号：US12516251

    申请日：2007-12-11

    申请人： Harold Burns Brooks ,  Joyce Z. Crich ,  James Robert Henry ,  Hong-Yu Li ,  Jason Scott Sawyer ,  Yan Wang

    发明人： Harold Burns Brooks ,  Joyce Z. Crich ,  James Robert Henry ,  Hong-Yu Li ,  Jason Scott Sawyer ,  Yan Wang

    IPC分类号： A61K31/397 ,  C07D403/14 ,  A61K31/506 ,  C07D413/14 ,  A61K31/5377 ,  A61P35/00

    CPC分类号： C07D409/14

    摘要： The present invention provides novel imidazolidinonyl aminopyrimidine compounds believed to have clinical use for treatment of cancer through inhibiting Plk1. Formula I wherein: R1 is aminomethyl, (C1-C3 alkyl)aminomethyl, di(C1-C2 alkyl)aminomethyl, N-ethyl-N-methyl-aminomethyl, 1-aminoethyl, 1-((C1-C2 alkyl)amino)-ethyl, 3,3,3-trifluoro-propylaminomethyl, ethynyl, 2-hydroxy-ethoxy, 2-hydroxyethylaminomethyl, 2-cyanoethylaminomethyl, mopholin-4-ylmethyl, methoxymethoxymethyl, cyclopropyl, 1-azetidinylmethyl, 1-pyrrolidinylmethyl, or 1,3-dioxolan-2-yl; R2 is hydrogen or halo; R3 is hydrogen or halo; provided that at least one of R2 and R3 is hydrogen; R4 is hydrogen, methyl, or halo; and is a single bond that is either present or absent, or pharmaceutically acceptable salt thereof.

    摘要翻译： 本发明提供了被认为具有通过抑制Plk1治疗癌症的临床用途的新型咪唑烷基氨基嘧啶化合物。 式（I）其中：R1是氨基甲基，（C1-C3烷基）氨基甲基，二（C1-C2烷基）氨基甲基，N-乙基-N-甲基 - 氨基甲基，1-氨基乙基，1-（（C1-C2烷基） 乙基，3,3,3-三氟 - 丙基氨基甲基，乙炔基，2-羟基 - 乙氧基，2-羟乙基氨基甲基，2-氰基乙基氨基甲基，吗啉-4-基甲基，甲氧基甲氧基甲基，环丙基，1-氮杂环丁基甲基，1-吡咯烷基甲基， 3-二氧戊环-2-基; R2为氢或卤素; R3是氢或卤素; R2和R3中的至少一个是氢; R4是氢，甲基或卤素; 并且是存在或不存在的单键或其药学上可接受的盐。